MDFI is a novel biomarker for poor prognosis in LUAD: Background. Approximately 80% of lung cancers are non-small cell lung cancers (NSCLC). Lung adenocarcinoma (LUAD) is the main subtype of NSCLC. The incidence and mortality of… #oncology https://t.co/jB
17,936 followers
38 followers
RT @FrontOncology: New research: MDFI is a novel biomarker for poor prognosis in LUAD: Background Approximately 80% of lung cancers are no…
6,544 followers
New research: MDFI is a novel biomarker for poor prognosis in LUAD: Background Approximately 80% of lung cancers are non-small cell lung cancers (NSCLC). Lung adenocarcinoma (LUAD) is the main subtype of NSCLC. The incidence and mortality of… https://t.co